Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
4.130
+0.210 (5.36%)
Feb 10, 2026, 11:40 AM EST - Market open
Orchestra BioMed Holdings Market Cap
Orchestra BioMed Holdings has a market cap or net worth of $233.2 million as of February 10, 2026. Its market cap has increased by 15.10% in one year.
Market Cap
233.20M
Enterprise Value
141.56M
1-Year Change
15.10%
Ranking
Category
Stock Price
$4.13
Market Cap Chart
Since August 4, 2020, Orchestra BioMed Holdings's market cap has increased from $197.44M to $233.20M, an increase of 18.11%. That is a compound annual growth rate of 3.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 221.34M | -5.54% |
| Dec 31, 2025 | 234.33M | 54.11% |
| Dec 31, 2024 | 152.05M | -53.41% |
| Dec 29, 2023 | 326.34M | 191.65% |
| Dec 30, 2022 | 111.90M | -45.72% |
| Dec 31, 2021 | 206.14M | -21.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inhibikase Therapeutics | 232.53M |
| Protalix BioTherapeutics | 232.42M |
| Heron Therapeutics | 231.04M |
| MediWound | 228.48M |
| Nuvectis Pharma | 227.72M |
| Achieve Life Sciences | 226.24M |
| Silence Therapeutics | 224.36M |
| Arcturus Therapeutics Holdings | 215.10M |